ArticleFrontiers in immunology2022

Cannabidivarin alleviates neuroinflammation by targeting TLR4 co-receptor MD2 and improves morphine-mediated analgesia.

Xue Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.